Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Read more about Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Spain13720737.9Filed on 2014-11-26
Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Read more about Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Denmark13720737.9Filed on 2014-11-26
Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Read more about Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Germany13720737.9Filed on 2014-11-26
Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Read more about Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Switzerland13720737.9Filed on 2014-11-26
Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Read more about Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Belgium13720737.9Filed on 2014-11-26
STABILIZED SINGLE HUMAN CD4 DOMAINS AND FUSION PROTEINS Read more about STABILIZED SINGLE HUMAN CD4 DOMAINS AND FUSION PROTEINS US Patent 10,647,754Filed on 2017-10-16
HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR GLYPICAN-3 AND USE THEREOF Read more about HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR GLYPICAN-3 AND USE THEREOF US Patent 10,640,571Filed on 2017-12-15
Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof Read more about Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof Italy16166924.7Filed on 2012-04-19
Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof Read more about Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof United Kingdom16166924.7Filed on 2012-04-19
Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof Read more about Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof France16166924.7Filed on 2012-04-19